Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Who would want to buy just £2 of shares???
Who would want to sell just 90 shares???
26-Mar-21 14:45:49 0.995 201 Buy* 0.80 1.00 2.00 O
25-Mar-21 14:02:42 0.80 90 Sell* 0.80 1.00 0.72 O
25-Mar-21 14:02:42 0.80 2 Sell* 0.80 1.00 0.02 O
25-Mar-21 14:02:42 0.80 680 Sell* 0.80 1.00 5.44 O
25-Mar-21 14:02:42 0.80 570 Sell* 0.80 1.00 4.56 O
25-Mar-21 14:02:42 0.80 500 Sell* 0.80 1.00 4.00 O
25-Mar-21 14:02:42 1.00 1,400 Buy* 0.80 1.00 14.00 O
25-Mar-21 10:41:03 0.995 502 Buy* 0.80 1.00 4.99 O
25-Mar-21 09:29:34 0.805 222 Sell* 0.80 1.00 1.79
Share price is up and down today.
Most buys are at 0.8p
Fruitflow is a great product but there are many things going on today and tomorrow which
effects the share price relative to China and America trade conflict and the European Union and Great Britain trade conflicts and lockdown etc.
www.frontiersin.org/articles/10.3389/fnut.2020.583080/full
"Fruitflow is now recognized as a functional product by the European Food Safety Authority (EFSA) with a recognized health claim that states that Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow” (94). A 3 g dose (containing 65 mg of antiplatelet components) of Fruitflow® recently demonstrated antiplatelet effects that were approximately one-third the effect of 75 mg of aspirin in a double-blinded randomized clinical trial of 47 healthy subjects (95). Nutraceuticals such as these may serve as a safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding (19)."
"In September 2020 Fruitflow was recognised in a review article by the Frontiers in Nutrition journal www.frontiersin.org/articles/10.3389/fnut.2020.583080/full which stated that nutraceuticals such as Fruitflow may serve as:"
"'A safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding.'"
Sounds good to me, Last time when the market in general was in pain, and Provexis share price shot up from 0.6p to 21p over 6 months as Coca-Cola showed interest in adding Fruirtflow to their products and then because they could not get the taste right for Coca Cola they pulled out of deal..
We all know Fruitflow does work and now the latest news is Fruitflow is to be available to all across China.
Which sounds good to me.
The Corona Virus attacks your blood flow by causing severe blood clots so to build up your immune system I recommend you advise all your family and friends to take Fruitflow which has been scientifically proven by the EFSA to improve blood flow and stop internal blood clotting .
"The agreement announced today grants the Distributor exclusive rights to import, market and sell the Company's Fruitflow+ Omega-3 dietary supplement product in China through the CBEC channel, with immediate effect. The Distributor will purchase Fruitflow+ Omega-3 as required from the Company, and the Distributor will then market and sell Fruitflow+ Omega-3 in China through its existing network of e-commerce and other sales channels".
"Fruitflow+ Omega-3 is currently available to purchase from the Company's e-commerce website www.fruitflowplus.com, Amazon UK and Holland & Barrett. Subscriber numbers on the fruitflowplus.com website have been growing steadily, and they currently stand at a further new all-time high level."
Sounds good to me.
"Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow” (94). A 3 g dose (containing 65 mg of antiplatelet components) of Fruitflow® recently demonstrated antiplatelet effects that were approximately one-third the effect of 75 mg of aspirin in a double-blinded randomized clinical trial of 47 healthy subjects (95). Nutraceuticals such as these may serve as a safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding (19)."
"Generally, only a limited number of food-derived compounds have been investigated for their antiplatelet effects clinically as of yet, whereby fish oils are synonymous. However, there has been some success in developing antiplatelet nutraceuticals. One such product is a water-soluble tomato-based nutraceutical given the trademarked name Fruitflow®. Fruitflow is now recognized as a functional product by the European Food Safety Authority (EFSA) with a recognized health claim that states that Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow"
Fruitflow information going back 11 years:-
https://www.google.co.uk/search?hl=en&tbm=isch&source=hp&biw=994&bih=606&ei=1OZvX7HxONyHjLsPl-6fiAY&q=Provexis+and+Fruitflow&oq=Provexis+and+Fruitflow&gs_lcp=CgNpbWcQDDoFCAAQsQM6CAgAELEDEIMBOgIIADoECAAQHjoECAAQGFDRDljLYmCDfWgAcAB4AIABSIgBjgqSAQIyMpgBAKABAaoBC2d3cy13aXotaW1n&sclient=img&ved=0ahUKEwixq9rfk4jsAhXcA2MBHRf3B2EQ4dUDCAc
Need update this September 2020.**
From last results September 2019:- “significant multiple of existing Fruitflow sales.”
“Planned launch by By-Health, a £3bn listed Chinese dietary supplement business, of a number of Fruitflow based products in the Chinese market is progressing well. Potential sales volumes remain at a significant multiple of existing Fruitflow sales.”
“• By-Health has made a significant investment in nine separate studies in China, at its sole expense, in support of the Fruitflow based products which it plans to launch in China. Studies conducted in China are needed to obtain ‘blue cap’ health claim status for dietary supplements, as required by the Chinese State Administration for Market Regulation (SAMR).”
•" The five studies which have been completed by By-Health showed excellent results in use for Fruitflow, and provide strong evidence for By-Health in its regulatory submissions for Fruitflow. If a successful blue cap health claim is achieved it would be expected to result in some significant orders for Fruitflow, potentially at a multiple of Fruitflow’s existing annual sales."
From last results September 2019:- "significant multiple of existing Fruitflow sales."
"Planned launch by By-Health, a £3bn listed Chinese dietary supplement business, of a number of Fruitflow based products in the Chinese market is progressing well. Potential sales volumes remain at a significant multiple of existing Fruitflow sales."
"• By-Health has made a significant investment in nine separate studies in China, at its sole expense, in support of the Fruitflow based products which it plans to launch in China. Studies conducted in China are needed to obtain ‘blue cap’ health claim status for dietary supplements, as required by the Chinese State Administration for Market Regulation (SAMR)."
•" The five studies which have been completed by By-Health showed excellent results in use for Fruitflow, and provide strong evidence for By-Health in its regulatory submissions for Fruitflow. If a successful blue cap health claim is achieved it would be expected to result in some significant orders for Fruitflow, potentially at a multiple of Fruitflow’s existing annual sales."
Clearly shows the link with Provexis:- https://genimen.in/
Dr. Asim Duttaroy, (www.asimduttaroy.com) who is the inventor of the product and based in the scientific advisory board of Genimen. He is a globally recognized expert in the or Duttaroy He is currently Group Leader of Chronic Disease at the University of Oslo's Faculty of Medicine, and he is the editor in chief of the international peer reviewed journal Food & Nutrition Research."
"His scientific work has been published in reviews, book, and editorials. He owns several international patents. His discoveries of anti-thrombotic factors in tomatoes and kiwifruits are patented internationally and 2 companies, Provexis Limited (www.provexis.com) in UK, and IDIA AS (www.idia.no) in Norway are established to commercialize these discoveries."
2/9/2020
Holland & Barrett
Your product is back in stock
Hi there,
"We are pleased to let you know that Provexis Fruitflow + Omega 3 30 Capsules is now back in stock and available to purchase."
"This is a popular item, so hurry before it's gone!"
Provexis Fruitflow + Omega 3 30 Capsules
Why bother after all this time with no update news and then this RNS?
Looks like to me that under the under the
"FCA's Disclosure Guidance and Transparency Rules." Provexis has to declare their "total number of ordinary shares and voting rights in the Company is 2,070,821,507." because some one is showing an interest in buying the Provexis out. IMHO
RNS;- "The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company is 2,070,821,507."
"The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company "
"under the FCA's Disclosure Guidance and Transparency Rules."
Fruitflow + omega 3
Made in USA
https://i.postimg.cc/rw0yMjKT/screenshot-397.png
"•Take OPTIFLOW daily, a plant based scientifically-substantiated nutritional supplement. The first & only supplement ever formulated to combine breakthrough ingredients: FruitFlow® and resVida®, 2 complimenting ingredients that promote optimal cardiovascular circulation. Made in the US by Bricker Labs."
"A daily dose of just 150mg of Fruitflow natural water-soluble tomato extract can help to improve blood circulation by maintaining normal platelet aggregation, according to a 2010 article titled Scientific Opinion on the modification of the authorisation of a health claim related to water-soluble tomato concentrate and helps to maintain a healthy blood flow and benefits circulation pursuant to Article 13(5) of Regulation (EC) No 1924/2006 following a request in accordance with Article 19 of the Regulation (EC) No 1924/2006 published in EFSA Journal."
"While strengthening your immunity to fight against Covid-19 is important now, maintaining healthy blood circulation is vital to reduce your risk of developing serious illnesses in the future."
"This article is brought to you by Biogrow."